Cimiracemoside C

• UNSPSC Description:

  Cimiracemoside C is an active component of Cimicifuga racemosa, activates AMPK, has the potential activity against diabetes[1].

• Target Antigen:

  AMPK

• Type:

  Natural Products

• Related Pathways:

  Epigenetics;PI3K/Akt/mTOR

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/cimiracemoside-c.html

• Purity:

  99.55

• Solubility:

  DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  C[C@]12[C@@]3([H])[C@@]4(CC[C@@]1([C@]5([H])C(O[C@H](C(C)(O)C)[C@@]6([H])C[C@H]5C)(O6)[C@@H]2O)C)[C@@]7([C@@](C(C)([C@@H](O[C@@]8([H])[C@@H]([C@H]([C@@H](O)CO8)O)O)CC7)C)([H])CC3)C4

• Molecular Weight:

  620.81

• References & Citations:

  [1]Moser C, et al. Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice. Phytomedicine. 2014 Sep 25;21(11):1382-9.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  256925-92-5